Harm Reduction: A Research Agenda

Affiliations

¹ Department Philosophy, Faculty of Arts, University of Regina, 3737 Wascana Parkway, Office CL426, Regina, SK, S4S 0A2, Canada. Shannon.Dea@uregina.ca.
² Katharine A. Pearson Chair in Civil Society and Public Policy, Faculty of Law and Department of Philosophy, McGill University, New Chancellor Day Hall, Office 505, 3644 Peel St., Montreal, QC, H3A 1W9, Canada.

Editorial

Shannon Dea et al. Health Care Anal. 2020 Dec.

. 2020 Dec;28(4):299-301.

doi: 10.1007/s10728-020-00418-6. Epub 2020 Nov 3.

¹ Department Philosophy, Faculty of Arts, University of Regina, 3737 Wascana Parkway, Office CL426, Regina, SK, S4S 0A2, Canada. Shannon.Dea@uregina.ca.
² Katharine A. Pearson Chair in Civil Society and Public Policy, Faculty of Law and Department of Philosophy, McGill University, New Chancellor Day Hall, Office 505, 3644 Peel St., Montreal, QC, H3A 1W9, Canada.

No abstract available

References

1. White, A. (2004). Reagan’s AIDS legacy/silence equals death. In SFGate Jan 27, 2012.
1. Zigon J. A war on people: Drug user politics and a new ethics of community. Oakland: University of California Press; 2018.
1. O’Hare P. Merseyside, the first harm reduction conferences, and the early history of harm reduction. International Journal of Drug Policy. 2007;18(2):141–144. doi: 10.1016/j.drugpo.2007.01.003. - DOI - PubMed
1. Weinstock D. A harm reduction approach to the ethical management of the COVID-19 pandemic. Public Health Ethics. 2020 doi: 10.1093/phe/phaa026. - DOI
1. Kutscher E, Greene RE. A harm reduction approach to coronavirus disease 2019. JAMA Health Forum. 2020 doi: 10.1001/jamahealthforum.2020.0656. - DOI - PubMed